Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesus A Frias

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Developmental Biology|June 22, 2018
The transcription factor Tfap2e/AP-2ε plays a pivotal role in maintaining the identity of basal vomeronasal sensory neuronsJennifer M Lin, Ed Zandro M Taroc, Jesus A Frias, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2023
Quercetin selectively reduces expanded repeat RNA levels in models of myotonic dystrophySubodh K Mishra, Sawyer M Hicks, Jesus A Frias, et al.
Development (Cambridge, England)|April 29, 2020
Smad4-dependent morphogenic signals control the maturation and axonal targeting of basal vomeronasal sensory neurons to the accessory olfactory bulbAnkana S Naik, Jennifer M Lin, Ed Zandro M Taroc, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 11, 2025
MBNL loss of function in smooth muscle as a model for myotonic dystrophy associated gastrointestinal dysmotilityJanel A M Peterson, Jesus A Frias, Andrew N Miller, et al.
Human Molecular Genetics|August 24, 2024
Expression levels of core spliceosomal proteins modulate the MBNL-mediated spliceopathy in DM1Jiss M Louis, Jesus A Frias, Jacob H Schroader, et al.
Molecular Therapy. Nucleic Acids|October 11, 2024
Alternative splicing dysregulation across tissue and therapeutic approaches in a mouse model of myotonic dystrophy type 1Sawyer M Hicks, Jesus A Frias, Subodh K Mishra, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
CAG repeat-selective compounds reduce abundance of expanded CAG RNAs in patient cell and murine models of SCAsHannah K Shorrock, Asmer Aliyeva, Jesus A Frias, et al.
Iscience|April 28, 2022
Molecular characterization of myotonic dystrophy fibroblast cell lines for use in small molecule screeningJana R Jenquin, Alana P O'Brien, Kiril Poukalov, et al.
NAR Molecular Medicine|February 19, 2026
Identification of enzymatically modified isoquercitrin as a therapeutic lead for myotonic dystrophy type 1Subodh K Mishra, Sawyer M Hicks, Jesus A Frias, et al.
ACS Chemical Biology|February 20, 2026
Modified Polycyclic Compounds Rescue Mis-splicing in Myotonic Dystrophy Type 1 Disease ModelsJesus A Frias, Sawyer M Hicks, Hormoz Mazdiyasni, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Developmental Biology|June 22, 2018
The transcription factor Tfap2e/AP-2ε plays a pivotal role in maintaining the identity of basal vomeronasal sensory neuronsJennifer M Lin, Ed Zandro M Taroc, Jesus A Frias, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2023
Quercetin selectively reduces expanded repeat RNA levels in models of myotonic dystrophySubodh K Mishra, Sawyer M Hicks, Jesus A Frias, et al.
Development (Cambridge, England)|April 29, 2020
Smad4-dependent morphogenic signals control the maturation and axonal targeting of basal vomeronasal sensory neurons to the accessory olfactory bulbAnkana S Naik, Jennifer M Lin, Ed Zandro M Taroc, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 11, 2025
MBNL loss of function in smooth muscle as a model for myotonic dystrophy associated gastrointestinal dysmotilityJanel A M Peterson, Jesus A Frias, Andrew N Miller, et al.
Human Molecular Genetics|August 24, 2024
Expression levels of core spliceosomal proteins modulate the MBNL-mediated spliceopathy in DM1Jiss M Louis, Jesus A Frias, Jacob H Schroader, et al.
Molecular Therapy. Nucleic Acids|October 11, 2024
Alternative splicing dysregulation across tissue and therapeutic approaches in a mouse model of myotonic dystrophy type 1Sawyer M Hicks, Jesus A Frias, Subodh K Mishra, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
CAG repeat-selective compounds reduce abundance of expanded CAG RNAs in patient cell and murine models of SCAsHannah K Shorrock, Asmer Aliyeva, Jesus A Frias, et al.
Iscience|April 28, 2022
Molecular characterization of myotonic dystrophy fibroblast cell lines for use in small molecule screeningJana R Jenquin, Alana P O'Brien, Kiril Poukalov, et al.
NAR Molecular Medicine|February 19, 2026
Identification of enzymatically modified isoquercitrin as a therapeutic lead for myotonic dystrophy type 1Subodh K Mishra, Sawyer M Hicks, Jesus A Frias, et al.
ACS Chemical Biology|February 20, 2026
Modified Polycyclic Compounds Rescue Mis-splicing in Myotonic Dystrophy Type 1 Disease ModelsJesus A Frias, Sawyer M Hicks, Hormoz Mazdiyasni, et al.
Pageof 2